AI Sports Tech Leader Orreco Secures Backing, Builds Integrated Performance Ecosystem
January 27, 2026, 9:38 pm
Orreco, an Irish AI sports tech innovator, secured significant investment. Dallas Mavericks owner Mark Cuban spearheaded a $4M fundraising round. Multiple NBA stars also backed the firm. Orreco's core mission: revolutionize athlete injury prevention through AI. It also aims to optimize performance. The company actively expanded its portfolio. Strategic acquisitions followed. It absorbed Australian firm Data Driven Sports Analytics (DDSA). Then, it acquired Jennis, a women's hormone health platform. Olympic champion Jessica Ennis-Hill founded Jennis. These moves forged a comprehensive women's performance ecosystem. Orreco now integrates AI across biomechanics, hormone health, and menstrual cycle intelligence. This establishes a new global standard for elite athlete well-being and peak performance. The firm is setting new benchmarks.
Orreco stands at the forefront of sports technology. The Irish firm leverages Artificial Intelligence. Its mission: empower elite athletes. Orreco focuses on injury prevention. It also optimizes performance. This innovative approach attracted significant attention. Billionaire investor Mark Cuban took notice. He led a recent $4 million fundraising round. His investment signals strong confidence.
Cuban owns the Dallas Mavericks. He is a recognized tech titan. His involvement elevates Orreco's profile. Several current NBA stars also joined the funding. This broad investor base underscores Orreco's market potential. Major-winning golfers Padraig Harrington and Graeme McDowell were already investors. Their continued support further validates the company's vision.
Orreco's core technology is cutting-edge. It analyzes athlete movement. AI algorithms detect subtle changes. These changes can signal injury susceptibility. This represents a proactive strategy. It moves beyond traditional reactive injury management. The system aims to prevent non-contact injuries. Knee ligaments, hamstrings, and Achilles tendons are common targets. Its data-driven insights offer a crucial edge.
The $4 million Series A extension marked a pivotal moment. Government agency Enterprise Ireland contributed $1 million. This national backing emphasizes the company's importance. Orreco plans to create 30 new jobs. These positions will be based in Galway, Ireland. This move reinforces Ireland's growing status. The country is becoming a vibrant hub for sports tech innovation. Venture capital-backed firms flourish there. Ireland leads Europe in sports tech per capita.
Orreco's expansion is strategic. The company acquired Australian firm Data Driven Sports Analytics (DDSA). This acquisition broadens Orreco's capabilities. DDSA specializes in biomechanical analysis. It provides technical insights. Women’s tennis world No. 1 Aryna Sabalenka utilizes DDSA's expertise. The integration of DDSA strengthens Orreco's data offerings. It enhances the platform's ability to analyze athlete movement.
Further consolidating its position, Orreco completed another key acquisition. It purchased Jennis. Jennis is a women’s hormone health platform. Olympic gold medalist Dame Jessica Ennis-Hill founded Jennis. This acquisition signifies a major leap. Orreco now deeply penetrates the women's sports performance market. Jennis brings expert training programs. It also offers crucial wellness advice.
The integration of Jennis creates a powerful ecosystem. This ecosystem is specifically designed for women. It combines hormonal health IP. It integrates menstrual-cycle intelligence. This synergy forms the most advanced women’s performance platform globally. Orreco already operated FitrWoman. This platform serves England’s Lionesses. Now, FitrWoman, Jennis, and DDSA Computer Vision unite. They operate under the Orreco AI umbrella.
This comprehensive approach redefines athlete optimization. It moves beyond isolated data points. Orreco delivers a single intelligence platform. It merges diverse biological and biomechanical data. This unified system measures performance holistically. It understands complex physiological interactions. It optimizes outcomes for elite sportswomen.
The combined platform offers unprecedented insights. It analyzes an athlete's cycle. It considers hormone fluctuations. It assesses biomechanical efficiencies. All data converges through AI. This empowers coaches and athletes. They make informed decisions. Marginal gains become attainable. Peak performance becomes more consistent. Injury risk diminishes significantly.
Orreco’s client roster is impressive. Nine Premier League teams utilize its services. The Lionesses, England's national women's football team, are also clients. A new project with Major League Soccer (MLS) is set for 2026. These partnerships highlight Orreco's impact across elite sports. Its technology is becoming indispensable.
The company's vision extends beyond professional sports. Its methodologies hold promise for broader healthcare applications. Consumer well-being could also benefit. The AI-driven insights could democratize advanced performance analytics. This positions Orreco as a leader. It shapes the future of sports science. It influences personalized health solutions.
The strategic investments and acquisitions solidify Orreco's market leadership. Mark Cuban's backing provides capital and credibility. The integration of DDSA enhances technical depth. The Jennis acquisition establishes a dominant presence in women's health. Orreco is setting a new global benchmark. It continuously innovates. It propels athletes to new levels of success. The future of sports performance looks increasingly intelligent. Orreco leads this charge. The company continues its rapid growth. Its impact on athletic achievement is profound.
Orreco stands at the forefront of sports technology. The Irish firm leverages Artificial Intelligence. Its mission: empower elite athletes. Orreco focuses on injury prevention. It also optimizes performance. This innovative approach attracted significant attention. Billionaire investor Mark Cuban took notice. He led a recent $4 million fundraising round. His investment signals strong confidence.
Cuban owns the Dallas Mavericks. He is a recognized tech titan. His involvement elevates Orreco's profile. Several current NBA stars also joined the funding. This broad investor base underscores Orreco's market potential. Major-winning golfers Padraig Harrington and Graeme McDowell were already investors. Their continued support further validates the company's vision.
Orreco's core technology is cutting-edge. It analyzes athlete movement. AI algorithms detect subtle changes. These changes can signal injury susceptibility. This represents a proactive strategy. It moves beyond traditional reactive injury management. The system aims to prevent non-contact injuries. Knee ligaments, hamstrings, and Achilles tendons are common targets. Its data-driven insights offer a crucial edge.
The $4 million Series A extension marked a pivotal moment. Government agency Enterprise Ireland contributed $1 million. This national backing emphasizes the company's importance. Orreco plans to create 30 new jobs. These positions will be based in Galway, Ireland. This move reinforces Ireland's growing status. The country is becoming a vibrant hub for sports tech innovation. Venture capital-backed firms flourish there. Ireland leads Europe in sports tech per capita.
Orreco's expansion is strategic. The company acquired Australian firm Data Driven Sports Analytics (DDSA). This acquisition broadens Orreco's capabilities. DDSA specializes in biomechanical analysis. It provides technical insights. Women’s tennis world No. 1 Aryna Sabalenka utilizes DDSA's expertise. The integration of DDSA strengthens Orreco's data offerings. It enhances the platform's ability to analyze athlete movement.
Further consolidating its position, Orreco completed another key acquisition. It purchased Jennis. Jennis is a women’s hormone health platform. Olympic gold medalist Dame Jessica Ennis-Hill founded Jennis. This acquisition signifies a major leap. Orreco now deeply penetrates the women's sports performance market. Jennis brings expert training programs. It also offers crucial wellness advice.
The integration of Jennis creates a powerful ecosystem. This ecosystem is specifically designed for women. It combines hormonal health IP. It integrates menstrual-cycle intelligence. This synergy forms the most advanced women’s performance platform globally. Orreco already operated FitrWoman. This platform serves England’s Lionesses. Now, FitrWoman, Jennis, and DDSA Computer Vision unite. They operate under the Orreco AI umbrella.
This comprehensive approach redefines athlete optimization. It moves beyond isolated data points. Orreco delivers a single intelligence platform. It merges diverse biological and biomechanical data. This unified system measures performance holistically. It understands complex physiological interactions. It optimizes outcomes for elite sportswomen.
The combined platform offers unprecedented insights. It analyzes an athlete's cycle. It considers hormone fluctuations. It assesses biomechanical efficiencies. All data converges through AI. This empowers coaches and athletes. They make informed decisions. Marginal gains become attainable. Peak performance becomes more consistent. Injury risk diminishes significantly.
Orreco’s client roster is impressive. Nine Premier League teams utilize its services. The Lionesses, England's national women's football team, are also clients. A new project with Major League Soccer (MLS) is set for 2026. These partnerships highlight Orreco's impact across elite sports. Its technology is becoming indispensable.
The company's vision extends beyond professional sports. Its methodologies hold promise for broader healthcare applications. Consumer well-being could also benefit. The AI-driven insights could democratize advanced performance analytics. This positions Orreco as a leader. It shapes the future of sports science. It influences personalized health solutions.
The strategic investments and acquisitions solidify Orreco's market leadership. Mark Cuban's backing provides capital and credibility. The integration of DDSA enhances technical depth. The Jennis acquisition establishes a dominant presence in women's health. Orreco is setting a new global benchmark. It continuously innovates. It propels athletes to new levels of success. The future of sports performance looks increasingly intelligent. Orreco leads this charge. The company continues its rapid growth. Its impact on athletic achievement is profound.